$64.03
-0.20[-0.31%]
At close: Apr 24
$64.03
0[0.00%]
After Hours: 4:02PM EDT
LeMaitre Vascular
(NASDAQ:LMAT)Latest News for LeMaitre Vascular Stock (NASDAQ:LMAT)
LeMaitre Vascular Stock (NASDAQ: LMAT)
Categories: All
Wednesday, March 27, 2024
Tuesday, March 05, 2024
Wednesday, February 28, 2024
- Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To KnowBenzinga Insights - Feb 28, 2024, 12:00PM
- LeMaitre Vascular shares are trading higher after the company reported better-than-expected Q4 GAAP EPS results and issued strong Q1 and FY24 guidance.Benzinga Newsdesk - Feb 28, 2024, 11:41AM
- Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $69Benzinga Newsdesk - Feb 28, 2024, 11:36AM
Tuesday, February 27, 2024
- LeMaitre Vascular Sees Q1 EPS $0.36-$0.41 vs $0.34 Est., Sales $50.5M-$52.9M vs $50.21M Est.; Sees FY24 EPS $1.60-$1.71 vs $1.53 Est., Sales $209.7M-$214.3M vs $209.99M Est.Benzinga Newsdesk - Feb 27, 2024, 5:39PM
- Recap: LeMaitre Vascular Q4 EarningsBenzinga Insights - Feb 27, 2024, 4:45PM
- LeMaitre Vascular Q4 2023 GAAP EPS $0.38 Beats $0.36 Estimate, Sales $48.88M Miss $49.02M EstimateBenzinga Newsdesk - Feb 27, 2024, 4:42PM
- Earnings Scheduled For February 27, 2024Benzinga Insights - Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Tuesday, February 06, 2024
Thursday, December 28, 2023
Tuesday, December 12, 2023
Wednesday, November 29, 2023
Wednesday, November 22, 2023
Wednesday, November 01, 2023
- LeMaitre Vascular Sees Q4 EPS $0.34-$0.38 Vs $0.34 Est.; Revenue $48M-50M Vs $50.19M Est.; FY23 EPS $1.32-$1.36 Vs $1.28 Est. Revenue $192.6M-$194.6M Vs $195.01M Est.Benzinga Newsdesk - Nov 1, 2023, 5:43PM
- LeMaitre Vascular Q3 EPS $0.33 Beats $0.30 Estimate, Sales $47.41M Miss $47.59M EstimateBenzinga Newsdesk - Nov 1, 2023, 5:40PM
- Earnings Scheduled For November 1, 2023Benzinga Insights - Nov 1, 2023, 7:19AM
Monday, October 23, 2023
Wednesday, September 06, 2023
- Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform RatingVandana Singh - Sep 6, 2023, 3:04PM
- Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023Benzinga Insights - Sep 6, 2023, 11:00AM
- Oppenheimer Initiates Coverage On LeMaitre Vascular with Outperform Rating, Announces Price Target of $70Benzinga Newsdesk - Sep 6, 2023, 4:44AM
Thursday, August 03, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023Benzinga Insights - Aug 3, 2023, 11:00AM
- Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For ThursdayLisa Levin - Aug 3, 2023, 8:06AM
- Jefferies Downgrades LeMaitre Vascular to Hold, Raises Price Target to $67Benzinga Newsdesk - Aug 3, 2023, 5:49AM
Wednesday, August 02, 2023
Tuesday, August 01, 2023
Wednesday, May 24, 2023
Friday, May 19, 2023
Wednesday, May 03, 2023
- LeMaitre Vascular shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.Benzinga Newsdesk - May 3, 2023, 11:26AM
- Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023Benzinga Insights - May 3, 2023, 11:00AM
- Barrington Research Upgrades LeMaitre Vascular to Outperform, Announces $62 Price TargetBenzinga Newsdesk - May 3, 2023, 9:44AM
Tuesday, May 02, 2023
Thursday, April 20, 2023
Tuesday, March 14, 2023
Thursday, February 23, 2023
- LeMaitre Vascular Sees FY23 EPS $1.11-$1.20 Vs $1.19 Est.; FY23 Revenue $174.3M-$178.3M Vs $171.3M EstHappy Mohamed - Feb 23, 2023, 4:53PM
- LeMaitre Vascular Sees Q1 EPS $0.22-$0.27 Vs $0.26 Est; Q1 Revenue $42.6M-$45M Vs $40.93M EstHappy Mohamed - Feb 23, 2023, 4:51PM
- LeMaitre Vascular Sees Q1 EPS $0.22-$0.27 vs $0.26 Est., Sales $42.6M-$45M vs $40.93M Est.Bill Haddad - Feb 23, 2023, 3:59PM
- LeMaitre Vascular Q4 EPS $0.25 Misses $0.26 Estimate, Sales $41.00M Beat $40.99M EstimateBill Haddad - Feb 23, 2023, 3:58PM
- Earnings Scheduled For February 23, 2023Benzinga Insights - Feb 23, 2023, 5:18AM
Monday, October 31, 2022
Friday, October 28, 2022
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Oct 28, 2022, 1:59PM
- Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day SessionLisa Levin - Oct 28, 2022, 12:12PM
- LeMaitre Vascular shares are trading lower after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and FY22 EPS and sales guidance below analyst estimates.Benzinga Newsdesk - Oct 28, 2022, 10:37AM